fondation Innovative Medicines for Tuberculosis (iM4TB), Lausanne, VD | Swiss Graph

fondation Innovative Medicines for Tuberculosis (iM4TB)

ActiveFoundation721001 - Research and experimental development in the pharmaceutical industry

Enriching this profile

Discovering products, team, contacts and branding from the company's website. The page updates automatically when ready.

At a glance

fondation Innovative Medicines for Tuberculosis (iM4TB) is a Swiss Stiftung registered in Lausanne, VD. Its registered activity falls under Research and experimental development in the pharmaceutical industry.

AI Insight

Registry narrative generated from SHAB/SOGC facts.

Officers12Active Relations11Deleted Relations0SOGC Records10First Record24.01.2014Latest Activity17.02.2026

Registry Information

Renamed 2×

Formerly: fondation Innovative Medicines for Tuberculosis (iM4TB) · Fondation Innovative Medicines for Tuberculosis (iM4TB)

Swiss UID: CHE-270.892.523
Legal Name: fondation Innovative Medicines for Tuberculosis (iM4TB)
Legal Form: Foundation
Incorporated: 24 Jan 2014
Canton: VD
Status: Active
Country: Switzerland

Company Purpose

Translating…

NOGA Codes

(Industry classification)

721001Research and experimental development in the pharmaceutical industry

NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001

Industry Health

Registered Address

EPFL Innovation Park, bâtiment I, 1015 Lausanne

1015, Lausanne, VD

Companies at this address

Enrich from integrations

Pull data from your connected providers and merge it with the registry.

Registry Pulse

Registry pulse is a Pro feature

Auditor

Has auditor

PricewaterhouseCoopers SA

Since

Current Directors & Officers